These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32973491)

  • 21. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of subthreshold depression on health-related quality of life in patients with Parkinson's disease based on cognitive status.
    Schönenberg A; Zipprich HM; Teschner U; Grosskreutz J; Witte OW; Prell T
    Health Qual Life Outcomes; 2021 Mar; 19(1):107. PubMed ID: 33766054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.
    Kamble N; Bhattacharya A; Hegde S; Vidya N; Gothwal M; Yadav R; Pal PK
    Behav Brain Res; 2022 Mar; 422():113733. PubMed ID: 34998797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Timmers M; Van Nueten L; Salvadore G; Zaunbrecher D; Roeben B; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    J Neuropsychol; 2020 Mar; 14(1):69-84. PubMed ID: 30320954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown.
    Baschi R; Luca A; Nicoletti A; Caccamo M; Cicero CE; D'Agate C; Di Giorgi L; La Bianca G; Lo Castro T; Zappia M; Monastero R
    Front Psychiatry; 2020; 11():590134. PubMed ID: 33381057
    [No Abstract]   [Full Text] [Related]  

  • 30. Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.
    Lawson RA; Yarnall AJ; Duncan GW; Breen DP; Khoo TK; Williams-Gray CH; Barker RA; Collerton D; Taylor JP; Burn DJ;
    Parkinsonism Relat Disord; 2016 Jun; 27():47-53. PubMed ID: 27094482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical efficacy of the stratification medical treatment based on the risk estimation of motor complications in Parkinson's disease].
    Wan Y; Xiao RQ; Zhao JH; Zhang Y; Gan J; Wu N; Song L; Li L; Qi C; Chen W; Wang XJ; Liu ZG
    Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(7):491-498. PubMed ID: 35184502
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychological impairment in Parkinson's disease with and without depression.
    Tröster AI; Stalp LD; Paolo AM; Fields JA; Koller WC
    Arch Neurol; 1995 Dec; 52(12):1164-9. PubMed ID: 7492290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.
    Glonnegger H; Beyle A; Cerff B; Gräber S; Csoti I; Berg D; Liepelt-Scarfone I
    J Alzheimers Dis; 2016 Jul; 53(4):1475-84. PubMed ID: 27392856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.
    Becker S; Bäumer A; Maetzler W; Nussbaum S; Tkaczynska Z; Sulzer P; Timmers M; Van Nueten L; Salvadore G; Brockmann K; Streffer J; Berg D; Liepelt-Scarfone I
    Neuropsychology; 2020 May; 34(4):447-455. PubMed ID: 32191056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of the quality of life in Parkinson's disease: results of a cohort study from Southwest China.
    Wu Y; Guo XY; Wei QQ; Song W; Chen K; Cao B; Ou RW; Zhao B; Shang HF
    J Neurol Sci; 2014 May; 340(1-2):144-9. PubMed ID: 24679837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Quality of Life in Patients With Parkinson's Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study.
    Zhang L; Chen Y; Liang X; Wang L; Wang J; Tang Y; Zhu X
    Front Aging Neurosci; 2022; 14():846563. PubMed ID: 35493927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease.
    Xiang YQ; Xu Q; Sun QY; Wang ZQ; Tian Y; Fang LJ; Yang Y; Tan JQ; Yan XX; Tang BS; Guo JF
    Front Neurol; 2019; 10():121. PubMed ID: 30837940
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.
    Holden HM; Schweer CN; Tröster AI
    Mov Disord Clin Pract; 2022 Jan; 9(1):69-75. PubMed ID: 35005067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal Spontaneous Brain Activity in Early Parkinson's Disease With Mild Cognitive Impairment: A Resting-State fMRI Study.
    Wang Z; Jia X; Chen H; Feng T; Wang H
    Front Physiol; 2018; 9():1093. PubMed ID: 30154730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.